MOTS-c vs NAD+

The Dose Guy’s verdict

Oct 27, 2026
6 sources

Pick by age and goal. If you are training and want energy that holds up in a deficit, MOTS-c is the one I find interesting, run short and logged, because nobody has tested a dose of it in a person. If you are past 60 and chasing vitality, NAD+ is the better bet, since that is where your levels have actually fallen, and an oral precursor comes before any drip. Under 60 and healthy, NAD+ is an expensive afternoon you probably will not feel.

Which would I take?MOTS-c to train, NAD+ past 60.

How they differ

Both get sold as mitochondrial energy, and they work at opposite ends of it. NAD+ is supply: a coenzyme hundreds of reactions use to move energy and repair DNA, and your levels drift down with age. Topping it up makes sense where it has fallen, which is why the case gets stronger the older you are. MOTS-c is a message, a short peptide your mitochondria release when energy runs low, telling the cell to adapt the way it does to training and fasting. One refills a tank that drains with age; the other sends a training cue.

In practice the gap is proof of mechanism against proof of nothing. NAD+ has a human trial, and it showed exactly what it is sold on, more NAD+ inside cells, with nothing you could feel moving. MOTS-c has no human dosing trial at all, but its mouse data on endurance and metabolic aging lines up with what the training crowd reports. Neither has shown a healthy person a result they could feel.

The rhythm decides a lot. NAD+ is a capsule every morning or a few hours in a clinic chair once or twice a month. MOTS-c is a few pins a week around training. If needles are a dealbreaker, the needle-free routes are oral NR or NMN, the precursors your body turns into NAD+, or the formulated NAD+ capsule from the one trial. If the 500 in your search is a 500 mg vial of NAD+ for home pins, that is a community habit with no better evidence than the drip.

What the research shows

Nobody has compared them, and the evidence is lopsided: one short human trial for NAD+, mouse work for MOTS-c.

No head-to-head trial of MOTS-c against NAD+ exists, and no controlled human trial of injected MOTS-c exists at all.as of Aug 2026

Five days of oral formulated NAD+ raised whole-blood intracellular NAD by 53% versus placebo in the primary analysis of 50 adults. No secondary clinical, vital-sign, wellbeing, or wearable-derived endpoint survived correction for multiple testing.GeroScience 2026 · phase 0/1b · n=60

Intravenous NAD+ is less well characterized than oral precursor use and lacks strong clinical validation.Mol Biol Rep 2026 · review

MOTS-c enhanced physical performance in young, middle-aged, and old mice, and treatment begun at 23.5 months increased physical capacity and healthspan.Nat Commun 2021 · mouse aging

NAD+ has the human receipt and MOTS-c has the performance story. That is the whole split, and it is why age decides the pick.

How people run them

The community dose for MOTS-c is 5 to 10 mg sub-q, two to four times a week, pinned around fasted training or through a cut, and nobody arrived at it through a study. Run it for weeks, not months. No change in your training energy by the end of the first few weeks means no change at that dose.

NAD+ starts oral: NR or NMN at 300 to 500 mg every morning, no chair, no needle. If you go the clinic route, 250 to 500 mg as a slow drip once or twice a month, and treat drip speed as the side-effect dial. Keep NAD+ to mornings either way, because it can wreck your sleep.

They do not overlap, so switching is just stopping one. Under 60, run the MOTS-c alone and skip the NAD+. Stacking is common, and the version I’d defend is past 60: the oral precursor as the daily base, MOTS-c added as the experiment weeks later, once you know how the precursor alone feels. Start them together and you will never know which one did what.

MOTS-c5–10 mg, 2–4x/wkForum consensus, not a study dose. Pin around fasted training.

NAD+ oral300–500 mg/day NR/NMNThe precursor route, every morning. Try this before any drip.

NAD+ IV250–500 mg, 1–2x/monthSlow drip, 2–4 hours. Speed is the side-effect dial.

Bothprecursor + MOTS-cPrecursor first, MOTS-c weeks later, so you know what did what.

Side effects, side by side

NAD+ discomfort comes from how it goes in; MOTS-c’s risks are the ones nobody has measured:

anecdotalAn NAD+ drip run fast brings chest tightness, nausea, flushing, and anxiety. A slower drip eases them, and the first session is usually the roughest.

anecdotalNAD+ late in the day can cost you the night’s sleep. Take it before noon.

anecdotalInjection-site irritation on MOTS-c at standard sub-q volumes.

unknownMOTS-c works the same AMPK pathway as metformin, and its effect on blood sugar in a person is unmeasured. Fasted and shaky means eat.

unknownNeither has long-term safety data for a healthy person. MOTS-c has no human safety data at all, plus a cell signal toward senescence, so keep its courses short.